4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000118
EVP, Chief Business Officer sold 3,928 shares at $28.40 ($111,555)
- EVP, Chief Business Officer acquired 10,837 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-15 | Exercise or conversion : show line 1 in the form | +10,837 | 35,854 | D | ||
| 2025-04-16 | Sale : show line 2 in the form | −3,928 | $28.40 | $111,555 | 31,926 | D |
| Open-market sales · 3,928 sh · avg $28.40 · $111,555 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-15 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −10,837 | 66,511 | D |
Loading xslF345X05/edgardoc.xml…